Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sarcoglycan isoforms in skeletal muscle.

L A Liu1, E Engvall

  • 1Burnham Institute, La Jolla, California 92037, USA.

The Journal of Biological Chemistry
|December 23, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Laminin alpha2 deficiency-associated muscular dystrophy in a Maine coon cat.

The Journal of small animal practice·2003
Same author

Laminin alpha2 deficiency and muscular dystrophy; genotype-phenotype correlation in mutant mice.

Neuromuscular disorders : NMD·2003
Same author

Delivery of alpha- and beta-sarcoglycan by recombinant adeno-associated virus: efficient rescue of muscle, but differential toxicity.

Human gene therapy·2002
Same author

Mice with a targeted deletion of the tetranectin gene exhibit a spinal deformity.

Molecular and cellular biology·2001
Same author

Skeletal muscle cell hypertrophy induced by inhibitors of metalloproteases; myostatin as a potential mediator.

American journal of physiology. Cell physiology·2001
Same author

Rapid nongenomic effect of corticosterone on neuronal nicotinic acetylcholine receptor in PC12 cells.

Archives of biochemistry and biophysics·2001

Epsilon-sarcoglycan associates with other sarcoglycans in muscle, forming complexes similar to alpha-sarcoglycan. This explains residual sarcoglycans in certain muscular dystrophies.

Area of Science:

  • Muscle biology
  • Molecular genetics
  • Cellular and molecular physiology

Background:

  • The sarcoglycan complex is crucial for muscle integrity and dystrophin-associated glycoprotein assembly.
  • Mutations in sarcoglycan genes lead to limb-girdle muscular dystrophy.
  • The role and association of epsilon-sarcoglycan in muscle remain unclear.

Purpose of the Study:

  • To investigate the in vivo localization and association of epsilon-sarcoglycan within the sarcoglycan complex in skeletal muscle.
  • To determine if epsilon-sarcoglycan forms complexes with other sarcoglycans.
  • To explore the organization of sarcoglycan complexes during muscle cell differentiation.

Main Methods:

  • Utilized wild-type and alpha-sarcoglycan-deficient mice for in vivo studies.

Related Experiment Videos

  • Employed C2C12 myocytes for in vitro studies on muscle cell differentiation.
  • Analyzed sarcoglycan complex formation and localization.

    • Main Results:

    • Beta-, gamma-, and delta-sarcoglycan levels were reduced in alpha-sarcoglycan mutants, but epsilon-sarcoglycan levels remained unchanged.
    • Epsilon-sarcoglycan was found to be complexed with beta-, gamma-, and delta-sarcoglycans in both wild-type and mutant mice.
    • In differentiating C2C12 cells, alpha- and epsilon-sarcoglycans formed distinct complexes with beta-, gamma-, and delta-sarcoglycans, both localized to the cell surface.

    Conclusions:

    • Epsilon-sarcoglycan forms functional complexes with beta-, gamma-, and delta-sarcoglycans, suggesting a role similar to alpha-sarcoglycan.
    • The association of epsilon-sarcoglycan with other sarcoglycans explains the presence of residual sarcoglycans in alpha-sarcoglycan-deficient models.
    • These findings contribute to understanding the molecular basis of limb-girdle muscular dystrophy and sarcoglycan function.